Cargando…
The yearly rate of Relative Thalamic Atrophy (yrRTA): a simple 2D/3D method for estimating deep gray matter atrophy in Multiple Sclerosis
Despite a strong correlation to outcome, the measurement of gray matter (GM) atrophy is not being used in daily clinical practice as a prognostic factor and monitor the effect of treatments in Multiple Sclerosis (MS). This is mainly because the volumetric methods available to date are sophisticated...
Autores principales: | Menéndez-González, Manuel, Salas-Pacheco, José M., Arias-Carrión, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144089/ https://www.ncbi.nlm.nih.gov/pubmed/25206331 http://dx.doi.org/10.3389/fnagi.2014.00219 |
Ejemplares similares
-
MTA index: a simple 2D-method for assessing atrophy of the medial temporal lobe using clinically available neuroimaging
por: Menéndez-González, Manuel, et al.
Publicado: (2014) -
Indices of Regional Brain Atrophy: Formulae and Nomenclature
por: Menendez, Manuel, et al.
Publicado: (2015) -
The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis
por: Dupuy, Sheena L., et al.
Publicado: (2016) -
Gray Matter Atrophy to Explain Subclinical Oculomotor Deficit in Multiple Sclerosis
por: Kincses, Bálint, et al.
Publicado: (2019) -
Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2019)